A retrospective study of influence of IBD disease activity on COVID-19 severity
Latest Information Update: 06 Jul 2021
At a glance
- Drugs Tofacitinib (Primary) ; Ustekinumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- 06 Jul 2021 New trial record
- 23 May 2021 Results presented at the Digestive Disease Week 2021